🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/01/2014 | 48,57 | 50,99 | 48,46 | 50,69 | +6,50% | 5,21% | 39.081.282 |
| 10/01/2014 | 47,55 | 47,78 | 47,23 | 47,60 | +0,73% | 1,14% | 8.533.969 |
| 09/01/2014 | 47,54 | 47,71 | 47,08 | 47,25 | -0,54% | 1,32% | 9.771.447 |
| 08/01/2014 | 47,81 | 47,84 | 47,33 | 47,51 | -0,64% | 1,08% | 14.353.094 |
| 07/01/2014 | 47,67 | 48,09 | 47,65 | 47,81 | +0,74% | 0,92% | 10.475.598 |
| 06/01/2014 | 47,53 | 47,84 | 47,24 | 47,46 | +0,02% | 1,26% | 10.408.107 |
| 03/01/2014 | 47,22 | 47,71 | 47,19 | 47,45 | +0,48% | 1,09% | 6.743.880 |
| 02/01/2014 | 47,60 | 47,75 | 47,04 | 47,22 | -1,12% | 1,48% | 8.265.052 |
| 31/12/2013 | 47,46 | 47,79 | 47,26 | 47,76 | +0,22% | 1,11% | 8.881.695 |
| 30/12/2013 | 47,46 | 47,65 | 47,07 | 47,65 | +0,30% | 1,23% | 6.625.351 |
| 27/12/2013 | 47,49 | 47,61 | 47,26 | 47,51 | +0,14% | 0,74% | 4.448.026 |
| 26/12/2013 | 47,18 | 47,47 | 47,10 | 47,44 | +0,63% | 0,79% | 5.313.150 |
| 24/12/2013 | 47,17 | 47,40 | 46,98 | 47,15 | +0,10% | 0,89% | 4.457.039 |
| 23/12/2013 | 47,18 | 47,42 | 46,99 | 47,10 | +0,08% | 0,91% | 8.660.567 |
| 20/12/2013 | 46,62 | 47,19 | 46,40 | 47,06 | +1,09% | 1,68% | 17.611.745 |
| 19/12/2013 | 46,52 | 46,71 | 46,31 | 46,56 | -0,23% | 0,86% | 9.182.995 |
| 18/12/2013 | 45,68 | 46,69 | 45,47 | 46,66 | +2,09% | 2,67% | 14.200.086 |
| 17/12/2013 | 45,73 | 45,80 | 45,43 | 45,71 | -0,40% | 0,81% | 14.567.200 |
| 16/12/2013 | 46,09 | 46,36 | 45,70 | 45,89 | -0,60% | 1,45% | 11.893.962 |
| 13/12/2013 | 46,51 | 46,66 | 45,86 | 46,16 | +0,12% | 1,72% | 8.799.322 |
| 12/12/2013 | 46,35 | 46,55 | 45,83 | 46,11 | -1,29% | 1,54% | 12.169.062 |
| 11/12/2013 | 47,24 | 47,26 | 46,52 | 46,71 | -0,97% | 1,58% | 15.200.192 |
| 10/12/2013 | 47,02 | 47,28 | 46,85 | 47,17 | -0,26% | 0,91% | 10.727.747 |
| 09/12/2013 | 47,12 | 47,57 | 46,95 | 47,29 | +0,34% | 1,32% | 9.779.412 |
| 06/12/2013 | 46,88 | 47,30 | 46,72 | 47,13 | +1,19% | 1,24% | 7.758.554 |
| 05/12/2013 | 46,67 | 46,99 | 46,54 | 46,57 | -1,01% | 0,98% | 9.140.551 |
| 04/12/2013 | 47,33 | 47,38 | 46,58 | 47,05 | -0,90% | 1,67% | 12.001.277 |
| 03/12/2013 | 47,54 | 47,77 | 47,12 | 47,48 | -0,84% | 1,37% | 14.257.411 |
| 02/12/2013 | 47,46 | 48,11 | 47,46 | 47,88 | +0,70% | 1,37% | 15.541.735 |
| 29/11/2013 | 47,51 | 47,66 | 47,21 | 47,55 | +0,00% | 0,94% | 7.231.200 |